MUMBAI, April 22 (Reuters) - Strides Arcolab Ltd said on Thursday it has received a tentative U.S. FDA approval for adenosine injection, a generic version of Astellas Pharma's <4503.T> Adenoscan.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback